Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Hypertension2364 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A09107 | 31870950 | J Hepatol | Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension. | 2019 | Details |
| A09126 | 31865799 | Hypertension | Nonalcoholic Fatty Liver Disease: An Emerging Driver of Hypertension. | 2019 | Details |
| A09127 | 31865317 | Dig Dis | Nonalcoholic Fatty Pancreas Disease: Clinical Consequences. | 2019 | Details |
| A09146 | 31858523 | Histol Histopathol | Hepatocellular carcinoma in non-alcoholic fatty liver disease (NAFLD) - pathological evidence for a predominance of steatohepatitic inflammatory non-proliferative subtype. | 2019 | Details |
| A09207 | 31835505 | Nutrients | Weight Gain and De Novo Metabolic Disorders after Liver Transplantation. | 2019 | Details |
| A09215 | 31833859 | Am J Gastroenterol | Disease Severity Is Associated With Higher Healthcare Utilization in Nonalcoholic Steatohepatitis Medicare Patients. | 2020 | Details |
| A09233 | 31826068 | J Gastrointestin Liver Dis | Characterization of Patients with Biopsy-Proven Non-Alcoholic Fatty Liver Disease and Normal Aminotransferase Levels. | 2019 | Details |
| A09239 | 31822739 | Sci Rep | Pharmacological myeloperoxidase (MPO) inhibition in an obese/hypertensive mouse model attenuates obesity and liver damage, but not cardiac remodeling. | 2019 | Details |
| A09250 | 31817623 | J Clin Med | Higher Sodium Intake Assessed by 24 Hour Urinary Sodium Excretion Is Associated with Non-Alcoholic Fatty Liver Disease: The PREVEND Cohort Study. | 2019 | Details |
| A09265 | 31812510 | Gastroenterology | Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension. | 2019 | Details |
| A09269 | 31810499 | Syst Rev | The impact of environmental cadmium exposure on type 2 diabetes risk: a protocol for an overview of systematic reviews. | 2019 | Details |
| A09286 | 31805573 | Horm Res Paediatr | Increased Prevalence of Severe Obesity and Related Comorbidities among Patients Referred to a Pediatric Obesity Clinic during the Last Decade. | 2019 | Details |
| A09307 | 31797186 | Dig Dis Sci | Impact of NAFLD on the Incidence of Cardiovascular Diseases in a Primary Care Population in Germany. | 2019 | Details |
| A09343 | 31783920 | Syst Rev | Diabetes drugs for nonalcoholic fatty liver disease: a systematic review. | 2019 | Details |
| A09348 | 31782543 | Aliment Pharmacol Ther | The impact of modifiable risk factors on the long-term outcomes of non-alcoholic fatty liver disease. | 2019 | Details |
| A09359 | 31779112 | Nutrients | Dietary Patterns and Components in Nonalcoholic Fatty Liver Disease (NAFLD): What Key Messages Can Health Care Providers Offer? | 2019 | Details |
| A09391 | 31763058 | Am J Cardiovasc Dis | Preclinical cardiac disease in nonalcoholic fatty liver disease with and without metabolic syndrome. | 2019 | Details |
| A09405 | 31758951 | Metabolism | Curcumin analog CUR5-8 ameliorates nonalcoholic fatty liver disease in mice with high-fat diet-induced obesity. | 2019 | Details |
| A09409 | 31758496 | Clin Transl Oncol | Splenic volume as a biomarker of hepatic damage after chemotherapy in patients with resected colorectal liver metastases (CRLM). | 2019 | Details |
| A09420 | 31756645 | Cytokine | Leptin/adiponectin ratio correlates with hepatic steatosis but not arterial stiffness in nonalcoholic fatty liver disease in Japanese population. | 2019 | Details |
| A09462 | 31734987 | Zhonghua Gan Zang Bing Za Zhi | [Expert recommendations on standardized diagnosis and treatment for fatty liver disease in China (2019 revised edition)]. | 2019 | Details |
| A09495 | 31721770 | PLoS One | Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease. | 2019 | Details |
| A09514 | 31714387 | Eur J Gastroenterol Hepatol | Helicobacter pylori infection may increase the severity of nonalcoholic fatty liver disease via promoting liver function damage, glycometabolism, lipid metabolism, inflammatory reaction and metabolic syndrome. | 2020 | Details |
| A09565 | 31693695 | PLoS One | The impact of hepatic steatosis on portal hypertension. | 2019 | Details |
| A09572 | 31691175 | Curr Obes Rep | Metabolic Syndrome in Children and Adolescents: Diagnostic Criteria, Therapeutic Options and Perspectives. | 2019 | Details |
| A09593 | 31682638 | PLoS One | Nonalcoholic fatty liver disease is an early predictor of metabolic diseases in a metabolically healthy population. | 2019 | Details |
| A09594 | 31682518 | Endocr Pract | CLINICAL PRACTICE GUIDELINES FOR THE PERIOPERATIVE NUTRITION, METABOLIC, AND NONSURGICAL SUPPORT OF PATIENTS UNDERGOING BARIATRIC PROCEDURES - 2019 UPDATE: COSPONSORED BY AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY, THE OBESITY SOCIETY, AMERICAN SOCIETY FOR METABOLIC & BARIATRIC SURGERY, OBESITY MEDICINE ASSOCIATION, AND AMERICAN SOCIETY OF ANESTHESIOLOGISTS - EXECUTIVE SUMMARY. | 2019 | Details |
| A09611 | 31675427 | Hepatology | Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A09612 | 31675274 | Metab Syndr Relat Disord | Relevant Features in Nonalcoholic Steatohepatitis Determined Using Machine Learning for Feature Selection. | 2019 | Details |
| A09645 | 31661524 | PLoS One | Non-resolution of non-alcoholic fatty liver disease (NAFLD) among urban, adult Sri Lankans in the general population: A prospective, cohort follow-up study. | 2019 | Details |
| A09653 | 31657510 | Mol Nutr Food Res | The Buckwheat Iminosugar d-Fagomine Attenuates Sucrose-Induced Steatosis and Hypertension in Rats. | 2019 | Details |
| A09659 | 31656291 | J Med Invest | The Effect of Laparoscopic Sleeve Gastrectomy on Obesity and Obesity-related Disease : the Results of 10 Initial Cases. | 2019 | Details |
| A09679 | 31651571 | J Clin Gastroenterol | The Prevalence of Lean/Nonobese Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. | 2020 | Details |
| A09697 | 31642599 | HIV Med | Application of guidelines for the management of nonalcoholic fatty liver disease in three prospective cohorts of HIV-monoinfected patients. | 2019 | Details |
| A09709 | 31637670 | Obes Surg | What Is the Role of the New Index Relative Fat Mass (RFM) in the Assessment of Nonalcoholic Fatty Liver Disease (NAFLD)? | 2020 | Details |
| A09729 | 31632666 | Biomed Rep | Comparison of the effect of light alcohol consumption on Japanese men with and without fatty liver. | 2019 | Details |
| A09738 | 31630897 | Trends Endocrinol Metab | NAFLD and Atherosclerosis: Two Sides of the Same Dysmetabolic Coin? | 2019 | Details |
| A09739 | 31630534 | Am J Physiol Gastrointest Liver Physiol | Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer. | 2019 | Details |
| A09798 | 31606352 | Ann Hepatol | Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know? | 2019 | Details |
| A09804 | 31604107 | Life Sci | Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome. | 2019 | Details |
| A09812 | 31601203 | BMC Endocr Disord | Prevalence of cardiovascular risk factors in non-menopausal and postmenopausal inpatients with type 2 diabetes mellitus in China. | 2019 | Details |
| A09820 | 31598559 | Clin Exp Hepatol | Prevalence and risk factors of non-alcoholic fatty liver disease in southwest Iran: a population-based case-control study. | 2019 | Details |
| A09821 | 31598192 | World J Hepatol | Cirrhotic patients and older people. | 2019 | Details |
| A09832 | 31595464 | J Gen Intern Med | Low Awareness of Nonalcoholic Fatty Liver Disease in a Population-Based Cohort Sample: the CARDIA Study. | 2019 | Details |
| A09833 | 31595260 | Porto Biomed J | Prevalence and risk factors of sonographically detected non alcoholic fatty liver disease in a screening centre in Klang Valley, Malaysia: an observational cross-sectional study. | 2018 | Details |
| A09836 | 31594780 | BMJ | Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults. | 2019 | Details |
| A09838 | 31594173 | Zhonghua Nei Ke Za Zhi | [Characteristics and clinical significance of body composition in gout patients]. | 2019 | Details |
| A09901 | 31568518 | PLoS One | Letrozole treatment of pubertal female mice results in activational effects on reproduction, metabolism and the gut microbiome. | 2019 | Details |
| A09903 | 31567625 | J Clin Gastroenterol | Statin Use is Protective Against Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: A Case-control Study. | 2020 | Details |
| A09907 | 31566148 | Public Health Nutr | Adherence to the Dietary Approaches to Stop Hypertension (DASH) diet is associated with lower presence of non-alcoholic fatty liver disease in middle-aged and elderly adults. | 2019 | Details |
| A09909 | 31564942 | Diabetes Metab Syndr Obes | The interplay between abdominal aortic aneurysm, metabolic syndrome and fatty liver disease: a retrospective case-control study. | 2019 | Details |
| A09915 | 31562711 | J Assoc Physicians India | Association between Non- alcoholic Fatty Liver Disease and Left Ventricular Diastolic Dysfunction in Patients of Type 2 Diabetes. | 2019 | Details |
| A09916 | 31562685 | J Hepatobiliary Pancreat Sci | Decrease in major secondary bile acid, hyodeoxycholic acid, was the main alteration in hepatic bile acid compositions in a hypertensive nonalcoholic fatty liver disease model. | 2019 | Details |
| A09919 | 31560040 | Inflamm Bowel Dis | Onset of Ulcerative Colitis in a Patient with Nonalcoholic Fatty Liver Disease (NAFLD): Dramatic Effect of Plant-based Diet for NAFLD. | 2019 | Details |
| A09957 | 31543676 | World J Gastroenterol | Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation. | 2019 | Details |
| A09958 | 31543468 | Ann Hepatol | Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis. | 2019 | Details |
| A09980 | 31538216 | Herz | Cardiac abnormalities in patients with nonalcoholic fatty liver disease : Insights from auxiliary examinations. | 2019 | Details |
| A09982 | 31537030 | Semin Liver Dis | Peculiarities of Cirrhosis due to Nonalcoholic Steatohepatitis (NASH). | 2019 | Details |
| A09992 | 31533345 | Medicina (Kaunas) | Relationship Between Serum Uric Acid Levels and Nonalcoholic Fatty Liver Disease in Non-Obese Patients. | 2019 | Details |
| A10013 | 31524533 | Expert Opin Investig Drugs | Multi-drug approaches to NASH: what's in the development pipeline? | 2019 | Details |
| A10018 | 31523440 | BMJ Open Gastroenterol | Real-world comorbidities and treatment patterns among patients with non-alcoholic fatty liver disease receiving phosphatidylcholine as adjunctive therapy in Russia. | 2019 | Details |
| A10037 | 31517638 | Am J Gastroenterol | Histologic Findings of Advanced Fibrosis and Cirrhosis in Patients With Nonalcoholic Fatty Liver Disease Who Have Normal Aminotransferase Levels. | 2019 | Details |
| A10042 | 31516267 | J Clin Exp Hepatol | Screening of Cardiovascular Disease in Nonalcoholic Fatty Liver Disease: Whom and How? | 2019 | Details |
| A10046 | 31514755 | BMC Pediatr | Increased liver echogenicity and liver enzymes are associated with extreme obesity, adolescent age and male gender: analysis from the German/Austrian/Swiss obesity registry APV. | 2019 | Details |
| A10053 | 31510105 | Cells | New Rat Model of Advanced NASH Mimicking Pathophysiological Features and Transcriptomic Signature of The Human Disease. | 2019 | Details |
| A10067 | 31504710 | J Nutr | Food Insecurity May Be an Independent Risk Factor Associated with Nonalcoholic Fatty Liver Disease among Low-Income Adults in the United States. | 2020 | Details |
| A10100 | 31484207 | J Periodontol | Association between periodontal status and non-alcoholic fatty liver disease in a Korean adult population: A nationwide cross-sectional study. | 2019 | Details |
| A10111 | 31479572 | Liver Int | Association between non-alcoholic fatty liver disease and risk of new-onset atrial fibrillation in healthy adults. | 2019 | Details |
| A10139 | 31470786 | Curr Pharm Des | A Mitochondrial Approach to Cardiovascular Risk and Disease. | 2019 | Details |
| A10145 | 31470247 | J Trace Elem Med Biol | Aluminium levels in hair and urine are associated with overweight and obesity in a non-occupationally exposed population. | 2019 | Details |
| A10172 | 31455011 | Int J Environ Res Public Health | Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications. | 2019 | Details |
| A10197 | 31438482 | Int J Environ Res Public Health | Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way. | 2019 | Details |
| A10208 | 31432447 | Hepatol Int | Association of epicardial adipose tissue with non-alcoholic fatty liver disease: a meta-analysis. | 2019 | Details |
| A10213 | 31430314 | PLoS One | Non-invasive assessment of portal hypertension by multi-parametric magnetic resonance imaging of the spleen: A proof of concept study. | 2019 | Details |
| A10216 | 31428204 | Diabetol Metab Syndr | Incidence and risk factors for metabolic syndrome among urban, adult Sri Lankans: a prospective, 7-year community cohort, follow-up study. | 2019 | Details |
| A10221 | 31423319 | BMJ Open Gastroenterol | High potency multistrain probiotic improves liver histology in non-alcoholic fatty liver disease (NAFLD): a randomised, double-blind, proof of concept study. | 2019 | Details |
| A10224 | 31422063 | Lancet Diabetes Endocrinol | Metabolic health in the Middle East and north Africa. | 2019 | Details |
| A10265 | 31406138 | Sci Rep | TGR(mREN2)27 rats develop non-alcoholic fatty liver disease-associated portal hypertension responsive to modulations of Janus-kinase 2 and Mas receptor. | 2019 | Details |
| A10271 | 31404666 | Clin Gastroenterol Hepatol | Increasing Liver Fat Is Associated With Incident Cardiovascular Risk Factors. | 2019 | Details |
| A10324 | 31387736 | Lancet Gastroenterol Hepatol | Management of metabolic syndrome and cardiovascular risk after liver transplantation. | 2019 | Details |
| A10374 | 31366982 | Sci Rep | Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis. | 2019 | Details |
| A10377 | 31366455 | Gut | Epidemiology of chronic liver diseases in the USA in the past three decades. | 2019 | Details |
| A10422 | 31342672 | Obes Rev | A systematic review and meta-analysis estimating the population prevalence of comorbidities in children and adolescents aged 5 to 18 years. | 2019 | Details |
| A10437 | 31336526 | Diabetes Metab Syndr | Prevalence of non-alcoholic fatty liver disease in patients with diabetes mellitus, hyperlipidemia, obesity and polycystic ovary syndrome: A cross-sectional study in north of Iran. | 2019 | Details |
| A10476 | 31321014 | Ther Adv Chronic Dis | Effects of glucagon-like peptide 1 receptor agonists on comorbidities in older patients with diabetes mellitus. | 2019 | Details |
| A10487 | 31315327 | J Assoc Physicians India | Etiological Patterns, Liver Fibrosis Stages and Prescribing Patterns of Hepato-Protective Agents in Indian Patients with Chronic Liver Disease. | 2018 | Details |
| A10504 | 31309602 | Hepatology | Diabetes Is Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Cirrhosis From Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10535 | 31298151 | Curr Pharm Des | Obesity, Metabolic Syndrome and the Risk of Microvascular Complications in Patients with Diabetes mellitus. | 2019 | Details |
| A10539 | 31294345 | J Obes Metab Syndr | Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10560 | 31290748 | Turk J Gastroenterol | Association of obesity with chronic kidney disease in elderly patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A10575 | 31283527 | Eur J Gastroenterol Hepatol | Sarcopenia assessed using bioimpedance analysis is associated independently with significant liver fibrosis in patients with chronic liver diseases. | 2020 | Details |
| A10589 | 31279739 | Metabolism | Laparoscopic sleeve gastrectomy reverses non-alcoholic fatty liver disease modulating oxidative stress and inflammation. | 2019 | Details |
| A10608 | 31273595 | Dig Dis Sci | Survey of Nonalcoholic Fatty Liver Disease Knowledge, Nutrition, and Physical Activity Patterns Among the General Public in Beijing, China. | 2019 | Details |
| A10684 | 31236937 | Australas J Dermatol | Nonalcoholic fatty liver disease puts patients with psoriasis at greater cardiovascular risk. | 2019 | Details |
| A10696 | 31233751 | Eur J Pharmacol | Zoledronic acid prevents the hepatic changes associated with high fat diet in rats; the potential role of mevalonic acid pathway in nonalcoholic steatohepatitis. | 2019 | Details |
| A10719 | 31223344 | Diabetol Metab Syndr | Insulin resistance exhibits varied metabolic abnormalities in nonalcoholic fatty liver disease, chronic hepatitis B and the combination of the two: a cross-sectional study. | 2019 | Details |
| A10746 | 31213030 | J Clin Med | A Systematic Review of NAFLD-Associated Extrahepatic Disorders in Youths. | 2019 | Details |
| A10752 | 31209928 | J Hum Nutr Diet | Prospective study of perceived dietary salt intake and the risk of non-alcoholic fatty liver disease. | 2019 | Details |
| A10753 | 31209721 | Dig Dis Sci | Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension. | 2019 | Details |
| A10765 | 31204306 | Obes Res Clin Pract | Neighbourhood socioeconomic circumstances, adiposity and cardiometabolic risk measures in children with severe obesity. | 2019 | Details |